Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Hasin Feroz"'
Autor:
Yue-xiao Shen, Woochul Song, D. Ryan Barden, Tingwei Ren, Chao Lang, Hasin Feroz, Codey B. Henderson, Patrick O. Saboe, Daniel Tsai, Hengjing Yan, Peter J. Butler, Guillermo C. Bazan, William A. Phillip, Robert J. Hickey, Paul S. Cremer, Harish Vashisth, Manish Kumar
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Synthetic polymeric membranes used for separations suffer from permeability-selectivity trade-offs. Here the authors demonstrate how a bioinspired pillar[5]arene artificial water channel embedded in a copolymer membrane can improve selectivity while
Externí odkaz:
https://doaj.org/article/7bdfb35557eb4ca3a14afd63527ed05d
Autor:
Yue-xiao Shen, Woochul Song, D. Ryan Barden, Tingwei Ren, Chao Lang, Hasin Feroz, Codey B. Henderson, Patrick O. Saboe, Daniel Tsai, Hengjing Yan, Peter J. Butler, Guillermo C. Bazan, William A. Phillip, Robert J. Hickey, Paul S. Cremer, Harish Vashisth, Manish Kumar
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-1 (2018)
The original version of this Article contained an error in the spelling of the author Woochul Song, which was incorrectly given as Woochul C. Song. This has been corrected in both the PDF and HTML versions of the Article.
Externí odkaz:
https://doaj.org/article/1c5b1d0d9b1845fc8ccfd385224c0d83
Publikováno v:
Biotechnology progressREFERENCES.
Biologics manufacturing is capital and consumable intensive with need for advanced inventory planning to account for supply chain constraints. Early-stage process design and technology transfer are often challenging due to limited information on proc
Autor:
Zheng Jian Li, Dhanuka P. Wasalathanthri, Letha Chemmalil, Hasin Feroz, Douglas Both, Gregory Lane, Jessica Hung, Melissa Holstein, Julia Ding, Neha Puri, Sanchayita Ghose
Publikováno v:
Biotechnology and Bioengineering. 117:3766-3774
Technologies capable of monitoring product quality attributes and process parameters in real time are becoming popular due to the endorsement of regulatory agencies and also to support the agile development of biotherapeutic pipelines. The utility of
Autor:
Matthew Billups, Mirko Minervini, Melissa Holstein, Hasin Feroz, Swarnim Ranjan, Jessica Hung, Haiying Bao, Zheng Jian Li, Sanchayita Ghose, Andrew L. Zydney
Publikováno v:
Biotechnology progressREFERENCES. 38(2)
Virus removal filtration is a critical step in the manufacture of monoclonal antibody products, providing a robust size-based removal of both enveloped and non-enveloped viruses. Many monoclonal antibodies show very large reductions in filtrate flux
Detergent-mediated virus inactivation (VI) provides a valuable orthogonal strategy for viral clearance particularly for next generation continuous manufacturing. Furthermore, there exists an industry-wide need to replace the conventionally employed d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d3da6ad150592a45dc9285b3144428e
https://doi.org/10.22541/au.163415854.45754951/v1
https://doi.org/10.22541/au.163415854.45754951/v1
Autor:
Sanchayita Ghose, Daniel Cetnar, Satish Sharma, Robert Hewlett, Zheng Jian Li, Hasin Feroz, Melissa Holstein
Publikováno v:
Biotechnology journalREFERENCES. 16(12)
Viral surrogates to screen for virus inactivation (VI) can be a faster, cheaper and safer alternative to third-party testing of pathogenic BSL2 (Biosafety level 2) model viruses. Although the bacteriophage surrogate, O6, has been used to assess low p
Autor:
Hasin Feroz, Daniel Cetnar, Robert Hewlett, Satish Sharma, Melissa Holstein, Sanchayita Ghose, Zheng Jian Li
Viral surrogates to screen for virus inactivation (VI) can be a faster, cheaper and safer alternative to third-party testing of pathogenic BSL2 (Biosafety Level 2) model viruses. Although the bacteriophage surrogate, Ø6, has been used to assess low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cf65dabdb9c389d802d8b08615e16a5
https://doi.org/10.22541/au.161772724.45671321/v1
https://doi.org/10.22541/au.161772724.45671321/v1
Autor:
Caryn L. Heldt, Hasin Feroz, Swarnim Ranjan, Christa Meingast, Dylan G Turpeinen, Xuankuo Xu, Sanchayita Ghose, Zheng Jian Li, Pratik U. Joshi, Melissa Holstein
Publikováno v:
Biotechnology journalREFERENCES. 16(7)
BACKGROUND Therapeutic protein manufacturing would benefit by having an arsenal of ways to inactivate viruses. There have been many publications on the virus inactivation ability of arginine at pH 4.0, but the mechanism of this inactivation is unknow